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The Good Stuff
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Regulatory challenges to the
good stuff?
• 85%-90% of new chemicals are 
dropped from further review after 20-25 
days under the Toxic Substances 
Control Act (TSCA)
• 100% of potential nanoscale materials 
(NMs) receive further scrutiny
• The review and ultimate regulation of 
NMs takes about 6 – 24 months per 
substance1
1 Long timelines reflect the period to negotiate regulations, not reach a decision or 
assess a substance. 
4NMs under TSCA
• Chemical substances as defined by the Toxic 
Substances Control Act (TSCA)
• NMs not on the TSCA Inventory are new chemicals 
– Definition based on molecular identity, not other properties
– Examples are fullerenes and carbon nanotubes
• NMs on the TSCA inventory are existing chemicals 
– Some metal oxide particles as an example
– Coated particles or derivatives may require a consultation
• EPA paper on TSCA Inventory status of NMs
NMs under TSCA, cont
• New Chemicals Program for NMs 
– Low release, low exposure exemption (LoReX)
• Demonstrated low exposures  limited hazard assessment
– Pre-manufacture notices (PMN)
• Full risk assessment
• Limitations on proposed or future activities 
• Data development – Regulatory and voluntary 
• Voluntary approach for existing chemicals 
formally closed January 2010 (Agency still open 
to collaborations)
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NMs under TSCA, cont
• Regulatory approach for existing-
chemical based nanoscale materials
– Current
• Notices of substantial risk must be submitted
– Future….
• Broad nano-SNUR (proposal late 2010): require 
notification and regulatory review for any “new” 
nanomaterial of an existing chemical substance
• Section 8a (proposal late 2010): Data call-in, 
report use and exposure data for certain 
nanoscale chemicals 
• Section 4: Mandated testing – first one 
“announced.” Testing may be needed for certain 
nanomaterials.6
CNT risk assessment 
challenges
Stage of the RA
• Material 
Characterization AND 
P-Chem properties
• Exposures
– Occupational
– Environmental
– General public
• Hazards 
– Eco 
– Human health
Challenges
• No nomenclature 
system developed
• Generally, insufficient 
data to identify 
relevant properties
• Unclear test 
methods/relevance of 
results
• How does material 
characterization 
correlate with p-chem
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CNT risk assessment 
challenges
Stage of the RA
• Material 
Characterization AND 
P-Chem properties
• Exposures
– Occupational
– Environmental
– General public
• Hazards 
– Eco 
– Human health
Challenges
• Occupational
– Large agglomerates –
do these break down 
into respirable and 
inhalable particles that 
can reach the deep 
lung 
– How do CNTs 
disperse in lung/other 
biological fluids?
– Interpretation of 
workplace exposure 
monitoring reports…
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CNT risk assessment 
challenges
Stage of the RA
• Material 
Characterization AND 
P-Chem properties
• Exposures
– Occupational
– Environmental
– General public
• Hazards 
– Eco 
– Human health
Challenges
• Environmental
– Do releases of CNTs
escape the POTWs or 
do they sorb to 
sludge?
– If they escape the 
POTWs, would natural 
organic matter and 
sunlight lead to 
soluble transformation 
products?
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CNT risk assessment 
challenges
Stage of the RA
• Material 
Characterization AND 
P-Chem properties
• Exposures
– Occupational
– Environmental
– General public
• Hazards 
– Eco 
– Human health
Challenges
• General public
– Are CNTs chemically 
bound in composites 
or just embedded? 
– Exposures from 
incineration/landfilling?
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CNT risk assessment 
challenges
Stage of the RA
• Material 
Characterization AND 
P-Chem properties
• Exposures
– Occupational
– Environmental
– General public
• Hazards 
– Eco
– Human health
Challenges
• Eco:
– No acute effects at 
saturation due to low 
solubility? 
– Sample prep/test 
methods
– what about the 
possibility of chronic 
effects, especially on 
transformed products?
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CNT risk assessment 
challenges
Stage of the RA
• Material 
Characterization AND 
P-Chem properties
• Exposures
– Occupational
– Environmental
– General public
• Hazards 
– Eco 
– Human health
Challenges
• Human health:
– Relevance of aerosols 
and material 
characteristics from 
tox studies compared 
to occupational 
exposures
– Dose metrics/sample 
prep
– What is the right tox 
paradigm ?
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CNT regulatory approach
– Further material characterization
• Key to chemical identity and risk assessments
– Use restrictions 
• PPE for industrial settings
• Must be embedded in a polymer/metal matrix 
for commercial or consumer settings
• Certain end uses not allowed 
– 90-day inhalation tox studies (to date)
– Limit releases to environment AND/OR 
Fate/Eco testing of CNTs
– Additional testing via other sources
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Other NMs that would be “new” 
chemicals under TSCA
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Coated metal 
particles
Highly functionalized 
materials
Fullerenes and 
modified fullerenes
Graphene
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Voluntary Program Interim 
Conclusions
• 2/3 of commercially available chemicals 
and 90% of NMs were not reported.
• Uncertainty surrounding submitters and 
submissions
• Companies are not inclined to 
voluntarily test their NMs
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How ORD is Allocating its Nano Resources
50% Sources, Fate, Transport, and Exposure
30% Human Health and Ecological Effects
10% Risk Assessment Methods and Case Studies
10% Preventing and Mitigating Risks
Challenges: 
Potential Release and Exposure: How 
much of what materials are/will be 
produced for what uses?
Properties: What properties make a material 
toxic, mobile, persistent, and bioavailable?
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Nanotechnology EHS Budget
Total NNI and EPA/ORD ($ Million)
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OECD WPMN Projects
• Project 1: Database on Safety Research
• Project 2: Research Strategies on Manufactured Nanomaterials
• Project 3: Safety Testing of a Representative Set of 
Manufactured Nanomaterials
• Project 4 : Manufactured Nanomaterials and Test Guidelines
• Project 5: Co-operation on Voluntary Schemes and Regulatory 
Programmes
• Project 6: Co-operation on Risk Assessment
• Project 7: Alternative Methods in Nano Toxicology
• Project 8: Exposure Measurement and Exposure Mitigation
• Project 9: Environmentally Sustainable Use of Manufactured 
Nanomaterials
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WPMN Project 3: Safety
• “Dataset” – 59 tests 
– Physical-chemical properties
– Materials characterization
– Environmental fate
– Environmental toxicity
– Mammalian toxicity
– Safety
• Alternative approaches and methods, including 
in vitro
• Investigation of different particle sizes, shapes, 
coatings and/or modifications
Material Lead sponsor(s) Co-sponsor(s) Contributor
Fullerenes(C60) Japan, US Denmark, China 
SWCNTs
Japan, US Canada, France, Germany, EC, China, 
BIAC 
MWCNTs
Japan, US Korea, BIAC Canada, Germany, France, EC, China, 
BIAC
Silver nanoparticles
Korea, US Australia, Canada, 
Germany, Nordic Council
France, EC, China
Iron nanoparticles BIAC, China Canada, US, Nordic Council
Carbon black Canada, Denmark, Germany. US
Titanium dioxide 
France, Germany  Austria, Canada, Korea, 
Spain, US, BIAC
China, Denmark, Japan
Aluminium oxide Germany, US, Japan
Cerium oxide 
US, UK/BIAC Australia, Netherlands, 
Spain  
Germany, Switzerland, EC, Japan
Zinc oxide UK/BIAC Australia, Spain US, BIAC Canada, Japan
Silicon dioxide 
France, EC Belgium, Korea, BIAC Denmark, Japan
Polystyrene Austria, Korea
Dendrimers Spain, US
Nanoclays  Denmark, US
22
Priority Needs (beyond EPA, beyond R&D) 
to Better Inform Policy Decisions
• Green chemistry and life cycle-focused 
research that advances sustainable nanotechnology
• New decision-analysis approaches to more 
quickly and effectively use scientific information to 
inform decisions that weigh the benefits and impacts 
of technologies across product life cycles
• Better collaborations within and across all sectors: 
government (including state and local), industry, and 
academia
Here is where we have great opportunities, 
with ECOS, the OECD and others, to enhance 
information flows in all directions.
WPMN Project 9: Sustainability
– To enhance the knowledge base about life cycle 
aspects of manufactured nanomaterials, as well 
as positive and negative impacts on environment 
and health of certain nano-enabled applications 
at their different  stages of development. 
– Tools and frameworks for life cycle 
considerations will be developed and applied to 
some selected cases of nano-enabled 
applications that demonstrate potential for 
environmental sustainability. 
– To pursue options for a broader initiative 
focusing on maximising environmental benefits 
and minimising risks of nano-enabled 
applications together with OECD partners.
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Some final thoughts
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• Potential implications for manufacturers/ 
high-tech downstream users of NMs
– Potentially longer lead times for NMs to be 
added to commercial toolkits
– Increased burden
– Greater long-term societal acceptance of 
technology 
• Opportunities to establish and capitalize 
on “greenness” as well as identify 
problem areas earlier in the innovation 
cycle 
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Contact Info
http://www.epa.gov/oppt/nano/
markey.kristan@epa.gov
202 564-8716
alwood.jim@epa.gov
202 564-8974
